Newell Brands: Baby-Step Recovery, But Shareholders Could Get Rubbed Away — Strong Sell
By Press Room
1 Mins read
This article was written by Follow Always on the hunt for undervalued, promising stocks with a focus on risk and reward. Limited…
This article was written by Follow Pearl Gray is a proprietary investment fund and independent market research firm. We primarily focus on…
Integra Resources: De-Risked Assets And A Strong Balance Sheet (NYSE:ITRG)
By Press Room
1 Mins read
This article was written by Follow I am an investor specializing in the consumer products sector with a focus on identifying companies…
First Majestic Silver (AG): Scale, Discipline, And Beta To Silver Make It A Strong Buy
By Press Room
1 Mins read
This article was written by Follow I work on the buy-side in Fixed Income. In my spare time, I’m out here Seeking…
FDL: Gets The Job Done, But Underwhelming Against Peer Dividend ETFs (Downgrade) (FDL)
By Press Room
1 Mins read
This article was written by Follow Financial analyst by day and a seasoned investor by passion, I’ve been involved in the world…
Dividend Champion, Contender, And Challenger Highlights: Week Of January 4
By Press Room
1 Mins read
This article was written by Follow Justin Law has a Ph.D in Chemistry from Rice University and has earned the CFA Institute…
SchiffGold is a full-service, discount precious metals dealer specializing in investment-grade gold and silver bullion. We offer a range of related services,…
LyondellBasell Stock: 12% Divvy Yield But It Is At Risk Of Getting Cut (NYSE:LYB)
By Press Room
2 Mins read
This article was written by Follow I aim to provide alpha-generating investment ideas. I am an independent investor managing my family’s portfolio,…
BITO Vs. BTCI ETF: Why This 78% Yield Is A Structural Underperformer (NYSEARCA:BITO)
By Press Room
1 Mins read
This article was written by Follow My professional journey in the investment field began in 2011. Today, I combine the roles of…
Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (NASDAQ:OMER)
By Press Room
1 Mins read
This article was written by Follow With a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines,…